GL1X · GenesisL1 explorer

Research workbench

Structure of apo oxa-143 carbapenemase

Analyse Structure of apo oxa-143 carbapenemase in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5IY2
Type
protein
Length
481 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-lactamase oxa-143
UniProt
D0UHC8
Pockets
3 · best druggability 0.59

Structure

x-ray diffraction · 2 distinct chains · 42% helix, 22% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-lactamase oxa-143protein24142% helix, 22% strandD0UHC8
BBeta-lactamase oxa-143protein24042% helix, 22% strandD0UHC8

Ligands and binding sites

  • GOL · Glycerol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11200.590.8521empty
22830.580.7738GOL
31770.460.7531empty

Interfaces

1 interface between chains.

  • A–B · 511 Ų buried · 0 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 modified (carboxylation).

Compared structures

  • 5IY2 · Structure of apo OXA-143 carbapenemase · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.